Qiagen NV (QGEN) PT Raised to $50 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $50.36 +0.28%
Rating Summary:
12 Buy, 19 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 25 | New: 16
Rating Summary:
12 Buy, 19 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 25 | New: 16
Join SI Premium – FREE
UBS analyst John Sourbeer raised the price target on Qiagen NV (NYSE: QGEN) to $50.00 (from $48.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Bright Minds Biosciences Inc. (DRUG) PT Lowered to $107 at Baird amid partial clinical hold
- Teladoc (TDOC) PT Raised to $11 at Piper Sandler
- CRH plc (CRH) PT Raised to $120 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
